Effective April 1, 2016, Humana will remove generic Renvela (sevelamer) from its Medicare formularies. Brand-name Renvela will remain on Humana’s formularies.
Patients currently taking the generic drug sevelamer will not be impacted by this change, and Humana will continue to cover the generic medication for these patients until the end of the plan year.
Prescribers with questions regarding this change may call 1-800-555-CLIN (1-800-555-2546), Monday through Friday, 8 a.m. to 8 p.m. Eastern time.
We want to alert you to a recall of Auvi-Q epinephrine injections, effective Oct. 26, 2015. We recommend you review your medical records and contact all patients for whom you have prescribed Auvi-Q to warn them of the following possible problem.
Sanofi US voluntarily recalled all Auvi-Q currently on the market, including the 0.15 mg and 0.3 mg strengths. This recall was initiated due to reports of possible device malfunctions that could result in inaccurate dosage delivery or failure to deliver the drug.
Auvi‑Q is packaged with two active devices and one trainer device in a corrugated box.
The recall includes the NDC and lot numbers in the table below.
|Auvi‑Q||2081278 through 3037230|
Patients who received the affected product should immediately contact their physician to request a prescription for an alternate epinephrine auto-injector. In the event of a life- threatening allergic reaction (anaphylaxis), members should only use their Auvi-Q device if another epinephrine auto-injector is not available, and then they should call 911.
Humana is notifying members who had pharmacy claims for Auvi-Q in the last 365 days about this drug recall.
For more information, contact Sanofi US at 1-877-319-8963 or 1-866-726-6340. Representatives are available Monday through Friday from 8 a.m. to 8 p.m. Eastern time.
Effective July 1, 2015, Humana will remove two drugs used to treat hepatitis C, Olysio and Victrelis, from its Medicare formularies. Two other drugs used to treat hepatitis C, Sovaldi and Harvoni, will remain on the formularies.
Patients taking Olysio and Victrelis as of June 30, 2015, will not be impacted by this change. These patients will have the same coverage for these medications until the end of the plan year.
Prescribers with questions regarding this change may call 1-800-555-CLIN (1-800-555-2546). Assistance is available Monday through Friday, 8 a.m. to 8 p.m. Eastern time. Please fax formulary exception requests to 1-877-486-2621 or mail them to: Humana Clinical Pharmacy Review, Attn: Medicare Part D coverage Determination, P.O. Box 33008, Louisville, KY 40128.
Effective Feb. 20, 2015, generic Nexium (esomeprazole) is not covered under any Humana Medicare Part D plan. Brand-name Nexium will continue to be covered on the preferred tier for all Humana Medicare Part D plans. Humana also will continue to cover generic Nexium on all commercial plans.
Prescribers with questions regarding this change may call 1-800-555-CLIN (1-800-555-2546) Monday through Friday, 8 a.m. to 8 p.m. Eastern time for more information.